Universal Ibogaine Inc. (TSXV:IBO)
Canada flag Canada · Delayed Price · Currency is CAD
0.0050
-0.0050 (-50.00%)
Feb 2, 2026, 9:30 AM EST

Universal Ibogaine Financials Overview

Millions CAD. Fiscal year is Aug - Jul.

Revenue & Profits

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY
Period EndingApr '25 Jul '24 Jul '23 Jul '22 Jul '21 Mar '21
Revenue
2.062.331.031.07--
Revenue Growth
-11.68%126.32%-3.81%---
Gross Profit
2.062.331.031.07--
Operating Income
0.36-0.03-1.68-3.08-3.8-0.29
Net Income
-0.41-1.18-2.02-10.5-3.87-0.29
Earnings Per Share
-0.010.010.060.03-0.03
EPS Growth
-0%-83.33%100.00%--

Cash & Debt

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY
Period EndingApr '25 Jul '24 Jul '23 Jul '22 Jul '21 Mar '21
Cash & Investments
0.130.370.310.730.142.17
Total Debt
2.572.652.781.740.410.06
Net Cash (Debt)
-2.44-2.28-2.46-1.01-0.272.11
Net Cash Growth
------
Net Cash Per Share
-0.01-0.01-0.01-0.01-0.000.22

Cash Flow & CapEx

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY
Period EndingApr '25 Jul '24 Jul '23 Jul '22 Jul '21 Mar '21
Operating Cash Flow
-0.64-0.84-1.1-4.33-3.25-0.21
Capital Expenditures
-0.02-0.08-0.36-0.1--
Free Cash Flow
-0.66-0.92-1.46-4.43-3.25-0.21
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY
Period EndingApr '25 Jul '24 Jul '23 Jul '22 Jul '21 Mar '21
Gross Margin
100.00%100.00%100.00%100.00%--
Operating Margin
17.31%-1.10%-162.81%-287.56%--
Pretax Margin
-19.67%-50.46%-195.80%-824.53%--
Profit Margin
-19.67%-50.46%-195.80%-824.53%--
FCF Margin
-32.20%-39.35%-141.50%-413.60%--

Valuation

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY
Period EndingAug '26 Jul '24 Jul '23 Jul '22 Jul '21 Mar '21
PE Ratio
-1.501.500.675.33-
PS Ratio
0.761.992.797.13--